AMSilk Funding Round

9/9/2025

Venture Equity

$61,000,000

Undisclosed

The company intends to use the funds to build further commercial traction and support its next phase of industrial scale-up, enabling to meet growing global demand for its silk-based protein materials.

Private & Independent

AgTech

Anna-Sigmund-Str. 1-3
Neuried / Munich, 82061
DE

AMSilk is the world's first industrial supplier of smart biotech materials with current scale-up phase by applying an outstanding technology protein platform based on silk proteins for a variety of applications such as textile fibers, medical devices and consumer goods. Always one step ahead, the Company aims to make smart biotech materials a part of everyday life through its customizable solutions. Furthermore, AMSilk's smart biotech materials outperform existing, fossil-based products not only through their optimal relationship between performance and positive environmental impact, but also through the adaptability of multiple benefits to a broad range of meaningful applications.